Quidel Corporation (QDEL): Price and Financial Metrics
GET POWR RATINGS... FREE!
QDEL POWR Grades
- QDEL scores best on the Value dimension, with a Value rank ahead of 95.08% of US stocks.
- The strongest trend for QDEL is in Growth, which has been heading up over the past 179 days.
- QDEL ranks lowest in Momentum; there it ranks in the 5th percentile.
QDEL Stock Summary
- Quidel Corp's stock had its IPO on March 3, 1992, making it an older stock than 81.48% of US equities in our set.
- QDEL's current price/earnings ratio is 6.72, which is higher than only 12.61% of US stocks with positive earnings.
- QDEL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 17.81% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Quidel Corp are PLAB, SMWB, APPN, BDR, and OSUR.
- Visit QDEL's SEC page to see the company's official filings. To visit the company's web site, go to www.quidel.com.
QDEL Valuation Summary
- QDEL's price/earnings ratio is 6; this is 83.56% lower than that of the median Healthcare stock.
- QDEL's price/earnings ratio has moved up 24.7 over the prior 243 months.
- Over the past 243 months, QDEL's EV/EBIT ratio has gone up 28.7.
Below are key valuation metrics over time for QDEL.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
QDEL | 2021-08-31 | 2.9 | 3.8 | 6.0 | 4.2 |
QDEL | 2021-08-30 | 2.9 | 3.8 | 6.0 | 4.3 |
QDEL | 2021-08-27 | 2.9 | 3.8 | 5.9 | 4.2 |
QDEL | 2021-08-26 | 2.8 | 3.7 | 5.8 | 4.1 |
QDEL | 2021-08-25 | 2.7 | 3.6 | 5.6 | 4.0 |
QDEL | 2021-08-24 | 2.8 | 3.6 | 5.6 | 4.0 |
QDEL Growth Metrics
- Its year over year cash and equivalents growth rate is now at 801.95%.
- The 4 year net income to common stockholders growth rate now stands at 753.4%.
- Its 4 year revenue growth rate is now at 204.51%.

The table below shows QDEL's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-12-31 | 1,698.551 | 805.869 | 704.226 |
2021-09-30 | 1,870.887 | 923.623 | 883.039 |
2021-06-30 | 1,837.209 | 917.019 | 899.555 |
2021-03-31 | 1,862.353 | 1,154.04 | 948.134 |
2020-12-31 | 1,661.668 | 629.763 | 810.287 |
2020-09-30 | 1,004.643 | 238.356 | 370.783 |
QDEL's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- QDEL has a Quality Grade of B, ranking ahead of 85.03% of graded US stocks.
- QDEL's asset turnover comes in at 1.046 -- ranking 21st of 680 Pharmaceutical Products stocks.
- SYRS, ONVO, and SESN are the stocks whose asset turnover ratios are most correlated with QDEL.
The table below shows QDEL's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 1.046 | 0.813 | 1.894 |
2021-03-31 | 1.203 | 0.825 | 2.292 |
2020-12-31 | 1.314 | 0.812 | 2.053 |
2020-09-30 | 0.980 | 0.739 | 1.094 |
2020-06-30 | 0.705 | 0.663 | 0.537 |
2020-03-31 | 0.625 | 0.614 | 0.329 |
QDEL Price Target
For more insight on analysts targets of QDEL, see our QDEL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $127.75 | Average Broker Recommendation | 1.8 (Moderate Buy) |
QDEL Stock Price Chart Interactive Chart >
QDEL Price/Volume Stats
Current price | $99.60 | 52-week high | $180.06 |
Prev. close | $98.99 | 52-week low | $88.05 |
Day low | $97.89 | Volume | 1,212,748 |
Day high | $101.10 | Avg. volume | 628,395 |
50-day MA | $106.17 | Dividend yield | N/A |
200-day MA | $121.78 | Market Cap | 4.17B |
Quidel Corporation (QDEL) Company Bio
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, womens health, and gastrointestinal diseases. The company was founded in 1979 and is based in San Diego, California.
Latest QDEL News From Around the Web
Below are the latest news stories about Quidel Corp that investors may wish to consider to help them evaluate QDEL as an investment opportunity.
Cerner (CERN) Q4 Earnings Surpass Estimates, Revenues MissCerner's (CERN) fourth-quarter results benefit from gains across four of its business units. |
LHC Group (LHCG) Q4 Earnings Miss Estimates, Revenues BeatDespite the weak bottom-line performance, LHC Group's (LHCG) fourth-quarter results benefit from organic growth in home health admissions. |
Wall Street Analysts Believe Quidel (QDEL) Could Rally 47%: Here's is How to TradeThe average of price targets set by Wall Street analysts indicates a potential upside of 46.8% in Quidel (QDEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
Quidel upgraded to Strong Buy at Raymond James on Ortho Clinical acquisitionThe COVID-19 test maker Quidel (QDEL +5.7%) is trading higher on Tuesday morning hours after Raymond James upgraded the stock to Strong Buy from Outperform, citing its proposed acquisition of Ortho Clinical Diagnostics. In December, Quidel (NASDAQ:QDEL) announced a deal to buy the pure-play in-vitro diagnostics player for nearly $6B.... |
Why Quidel Was Trouncing the Market on TuesdayA significant analyst upgrade keeps the stock''s bull run going. |
QDEL Price Returns
1-mo | -0.52% |
3-mo | -7.56% |
6-mo | -31.22% |
1-year | -17.03% |
3-year | 81.62% |
5-year | 299.84% |
YTD | -26.22% |
2021 | -24.86% |
2020 | 139.44% |
2019 | 53.69% |
2018 | 12.62% |
2017 | 102.38% |
Continue Researching QDEL
Here are a few links from around the web to help you further your research on Quidel Corp's stock as an investment opportunity:Quidel Corp (QDEL) Stock Price | Nasdaq
Quidel Corp (QDEL) Stock Quote, History and News - Yahoo Finance
Quidel Corp (QDEL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...